Report overview
The microneedle patch transdermal drug delivery system is applied to the patient's skin by attaching the microneedle to the drug delivery patch and effectively administering the drug for a certain period of time. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
This report contains market size and forecasts of Microneedle Patch Transdermal Drug Delivery Systems in global, including the following market information:
Global Microneedle Patch Transdermal Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Microneedle Patch Transdermal Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Microneedle Patch Transdermal Drug Delivery Systems companies in 2021 (%)
The global Microneedle Patch Transdermal Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solid Microneedles Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microneedle Patch Transdermal Drug Delivery Systems include 3M, Becton, Endoderma, BD, Zosano Pharma, Raphas, Nanopass Tech, Corium International and Valeritas, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Microneedle Patch Transdermal Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microneedle Patch Transdermal Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Patch Transdermal Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Global Microneedle Patch Transdermal Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Patch Transdermal Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Global Microneedle Patch Transdermal Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Patch Transdermal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microneedle Patch Transdermal Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Microneedle Patch Transdermal Drug Delivery Systems revenues share in global market, 2021 (%)
Key companies Microneedle Patch Transdermal Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Microneedle Patch Transdermal Drug Delivery Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Becton
Endoderma
BD
Zosano Pharma
Raphas
Nanopass Tech
Corium International
Valeritas
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
SNvia
Small Lab
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
